Table 2.
Correlations between change in serum cathepsin S concentrations and changes in weight and cardiometabolic risk factors during 6 weeks in the whole sample (n = 86)
| Characteristics | r | P-value | β-coefficient (95% CI) | P-value |
|---|---|---|---|---|
| Weight | 0.22 | 0.04 | 241.60 (3.37-479.81) | 0.05 |
| HOMA-IR | 0.04 | 0.72 | 166.02 (-734.40-1066.44) | 0.72 |
| LDL-C | 0.24 | 0.03 | 794.11 (84.86-1503.36) | 0.03 |
| HDL-C | 0.18 | 0.12 | 1914.54 (-505.34-4334.43) | 0.12 |
| TG | 0.02 | 0.84 | 114.98 (-1007.58-1237.56) | 0.84 |
| Cholesterol | 0.27 | 0.01 | 755.29 (163.79-1346.90) | 0.01 |
| SBP | 0.15 | 0.18 | 29.43 (-13.37-72.24) | 0.18 |
| DBP | 0.17 | 0.12 | 46.16 (-12.39-104.71) | 0.12 |
Data are correlation coefficients and regression coefficients, with 95% CI. All models are adjusted for sex. HOMA -IR: Homeostasis model assessment-insulin resistance, HDL-C:High-density lipoprotein cholesterol; LDL -C: Low-density lipoprotein cholesterol, TG: Triglycerides, SB P: Systolic blood pressure, DBP: Diastolic blood pressure; Pearson's correlation and Linear regression has been used.